 |
PDBsum entry 1cd2
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1cd2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.1.5.1.3
- dihydrofolate reductase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
Folate Coenzymes
|
 |
 |
 |
 |
 |
Reaction:
|
 |
(6S)-5,6,7,8-tetrahydrofolate + NADP+ = 7,8-dihydrofolate + NADPH + H+
|
 |
 |
 |
 |
 |
(6S)-5,6,7,8-tetrahydrofolate
|
+
|
NADP(+)
Bound ligand (Het Group name = )
corresponds exactly
|
=
|
7,8-dihydrofolate
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
NADPH
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
38:4303-4312
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+.
|
|
V.Cody,
N.Galitsky,
D.Rak,
J.R.Luft,
W.Pangborn,
S.F.Queener.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Structural data from two independent crystal forms (P212121 and P21) of the
folate (FA) binary complex and from the ternary complex with the oxidized
coenzyme, NADP+, and recombinant Pneumocystis carinii dihydrofolate reductase
(pcDHFR) refined to an average of 2.15 A resolution, show the first evidence of
ligand-induced conformational changes in the structure of pcDHFR. These data are
also compared with the crystal structure of the ternary complex of methotrexate
(MTX) with NADPH and pcDHFR in the monoclinic lattice with data to 2.5 A
resolution. Comparison of the data for the FA binary complex of pcDHFR with
those for the ternary structures reveals significant differences, with a >7 A
movement of the loop region near residue 23 that results in a new "flap-open"
position for the binary complex, and a "closed" position in the ternary
complexes, similar to that reported for Escherichia coli (ec) DHFR complexes. In
the orthorhombic lattice for the binary FA pcDHFR complex, there is also an
unwinding of a short helical region near residue 47 that places hydrophobic
residues Phe-46 and Phe-49 toward the outer surface, a conformation that is
stabilized by intermolecular packing contacts. The pyrophosphate moiety of NADP+
in the ternary folate pcDHFR complexes shows significant differences in
conformation compared with that observed in the MTX-NADPH-pcDHFR ternary
complex. Additionally, comparison of the conformations among these four pcDHFR
structures reveals evidence for subdomain movement that correlates with cofactor
binding states. The larger binding site access in the new "flap-open" loop 23
conformation of the binary FA complex is consistent with the rapid release of
cofactor from the product complex during catalysis as well as the more rapid
release of substrate product from the binary complex as a result of the weaker
contacts of the closed loop 23 conformation, compared to ecDHFR.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Gangjee,
W.Li,
L.Lin,
Y.Zeng,
M.Ihnat,
L.A.Warnke,
D.W.Green,
V.Cody,
J.Pace,
and
S.F.Queener
(2009).
Design, synthesis, and X-ray crystal structures of 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors.
|
| |
Bioorg Med Chem,
17,
7324-7336.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.R.Bourne,
R.A.Bunce,
P.C.Bourne,
K.D.Berlin,
E.W.Barrow,
and
W.W.Barrow
(2009).
Crystal structure of Bacillus anthracis dihydrofolate reductase with the dihydrophthalazine-based trimethoprim derivative RAB1 provides a structural explanation of potency and selectivity.
|
| |
Antimicrob Agents Chemother,
53,
3065-3073.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.S.Bolstad,
and
A.C.Anderson
(2009).
In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking.
|
| |
Proteins,
75,
62-74.
|
 |
|
|
|
|
 |
J.Liu,
D.B.Bolstad,
E.S.Bolstad,
D.L.Wright,
and
A.C.Anderson
(2009).
Towards new antifolates targeting eukaryotic opportunistic infections.
|
| |
Eukaryot Cell,
8,
483-486.
|
 |
|
|
|
|
 |
E.S.Bolstad,
and
A.C.Anderson
(2008).
In pursuit of virtual lead optimization: the role of the receptor structure and ensembles in accurate docking.
|
| |
Proteins,
73,
566-580.
|
 |
|
|
|
|
 |
V.Cody,
J.Pace,
and
A.Rosowsky
(2008).
Structural analysis of a holoenzyme complex of mouse dihydrofolate reductase with NADPH and a ternary complex with the potent and selective inhibitor 2,4-diamino-6-(2'-hydroxydibenz[b,f]azepin-5-yl)methylpteridine.
|
| |
Acta Crystallogr D Biol Crystallogr,
64,
977-984.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Cody,
J.Pace,
K.Chisum,
and
A.Rosowsky
(2006).
New insights into DHFR interactions: analysis of Pneumocystis carinii and mouse DHFR complexes with NADPH and two highly potent 5-(omega-carboxy(alkyloxy) trimethoprim derivatives reveals conformational correlations with activity and novel parallel ring stacking interactions.
|
| |
Proteins,
65,
959-969.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.C.Anderson
(2005).
Two crystal structures of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveal protein-ligand interactions including a structural basis for observed antifolate resistance.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
61,
258-262.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Cody,
J.R.Luft,
and
W.Pangborn
(2005).
Understanding the role of Leu22 variants in methotrexate resistance: comparison of wild-type and Leu22Arg variant mouse and human dihydrofolate reductase ternary crystal complexes with methotrexate and NADPH.
|
| |
Acta Crystallogr D Biol Crystallogr,
61,
147-155.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Nahimana,
M.Rabodonirina,
J.Bille,
P.Francioli,
and
P.M.Hauser
(2004).
Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis.
|
| |
Antimicrob Agents Chemother,
48,
4301-4305.
|
 |
|
|
|
|
 |
V.Cody,
J.R.Luft,
W.Pangborn,
A.Gangjee,
and
S.F.Queener
(2004).
Structure determination of tetrahydroquinazoline antifolates in complex with human and Pneumocystis carinii dihydrofolate reductase: correlations between enzyme selectivity and stereochemistry.
|
| |
Acta Crystallogr D Biol Crystallogr,
60,
646-655.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Nahimana,
M.Rabodonirina,
P.Francioli,
J.Bille,
and
P.M.Hauser
(2003).
Pneumocystis jirovecii dihydrofolate reductase polymorphisms associated with failure of prophylaxis.
|
| |
J Eukaryot Microbiol,
50,
656-657.
|
 |
|
|
|
|
 |
H.Zhao,
T.Bray,
M.Ouellette,
M.Zhao,
R.A.Ferre,
D.Matthews,
J.M.Whiteley,
and
K.I.Varughese
(2003).
Structure of pteridine reductase (PTR1) from Leishmania tarentolae.
|
| |
Acta Crystallogr D Biol Crystallogr,
59,
1539-1544.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.H.O'Neil,
R.H.Lilien,
B.R.Donald,
R.M.Stroud,
and
A.C.Anderson
(2003).
Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase.
|
| |
J Biol Chem,
278,
52980-52987.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.H.O'Neil,
R.H.Lilien,
B.R.Donald,
R.M.Stroud,
and
A.C.Anderson
(2003).
The crystal structure of dihydrofolate reductase-thymidylate synthase from Cryptosporidium hominis reveals a novel architecture for the bifunctional enzyme.
|
| |
J Eukaryot Microbiol,
50,
555-556.
|
 |
|
|
|
|
 |
V.Cody,
J.R.Luft,
W.Pangborn,
and
A.Gangjee
(2003).
Analysis of three crystal structure determinations of a 5-methyl-6-N-methylanilino pyridopyrimidine antifolate complex with human dihydrofolate reductase.
|
| |
Acta Crystallogr D Biol Crystallogr,
59,
1603-1609.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Cody,
N.Galitsky,
J.R.Luft,
W.Pangborn,
and
A.Gangjee
(2003).
Analysis of two polymorphic forms of a pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolate binary complex with human dihydrofolate reductase.
|
| |
Acta Crystallogr D Biol Crystallogr,
59,
654-661.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.A.Bottoms,
P.E.Smith,
and
J.J.Tanner
(2002).
A structurally conserved water molecule in Rossmann dinucleotide-binding domains.
|
| |
Protein Sci,
11,
2125-2137.
|
 |
|
|
|
|
 |
L.Y.Lin,
T.Sulea,
R.Szittner,
C.Kor,
E.O.Purisima,
and
E.A.Meighen
(2002).
Implications of the reactive thiol and the proximal non-proline cis-peptide bond in the Structure and function of Vibrio harveyi luciferase.
|
| |
Biochemistry,
41,
9938-9945.
|
 |
|
|
|
|
 |
V.Cody,
N.Galitsky,
J.R.Luft,
W.Pangborn,
A.Rosowsky,
and
S.F.Queener
(2002).
Structure-based enzyme inhibitor design: modeling studies and crystal structure analysis of Pneumocystis carinii dihydrofolate reductase ternary complex with PT653 and NADPH.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
946-954.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
V.Cody,
N.Galitsky,
J.R.Luft,
W.Pangborn,
S.F.Queener,
and
A.Gangjee
(2002).
Analysis of quinazoline and pyrido[2,3-d]pyrimidine N9-C10 reversed-bridge antifolates in complex with NADP+ and Pneumocystis carinii dihydrofolate reductase.
|
| |
Acta Crystallogr D Biol Crystallogr,
58,
1393-1399.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Wang,
J.A.Bruenn,
S.F.Queener,
and
V.Cody
(2001).
Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme.
|
| |
Antimicrob Agents Chemother,
45,
2517-2523.
|
 |
|
|
|
|
 |
V.Cody,
D.Chan,
N.Galitsky,
D.Rak,
J.R.Luft,
W.Pangborn,
S.F.Queener,
C.A.Laughton,
and
M.F.Stevens
(2000).
Structural studies on bioactive compounds. 30. Crystal structure and molecular modeling studies on the Pneumocystis carinii dihydrofolate reductase cofactor complex with TAB, a highly selective antifolate.
|
| |
Biochemistry,
39,
3556-3564.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |